- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
Clinical Trials on 난소 신생물 in Korea, Republic of
총 7619 건
-
Seoul National University Hospital완전한
-
Seoul National University Hospital알려지지 않은
-
Yonsei UniversityCanariaBio Inc.모병PARP 억제제 내성 난소암, 나팔관암 또는 원발성 복막암 환자는 백금 재치료 대상이 아닙니다.대한민국
-
Shanghai Gynecologic Oncology Group모병
-
BerGenBio ASA종료됨
-
China Academy of Chinese Medical SciencesDongzhimen Hospital, Beijing; Kyung Hee University Hospital at Gangdong; Korea Institute...알려지지 않은
-
Yonsei University모병
-
Asan Medical CenterBaxter Healthcare Corporation완전한
-
Korean Gynecologic Oncology Group알려지지 않은난소 암 | 나팔관암 | 원발성 복막암대한민국
-
Asan Medical Center모병
-
LG Life Sciences완전한
-
Asan Medical Center완전한
-
Boryung Pharmaceutical Co., Ltd완전한
-
Samsung Medical Center완전한
-
Samyang Biopharmaceuticals Corporation모병
-
Seoul National University HospitalAsan Medical Center; Korea University Guro Hospital; Ajou University School of Medicine; Ewha... 그리고 다른 협력자들빼는
-
Millennium Pharmaceuticals, Inc.종료됨
-
Samsung Medical Center모병
-
Seoul National University Bundang Hospital알려지지 않은
-
Seoul National University Hospital알려지지 않은
-
Ewha Womans University Mokdong HospitalSeoul St. Mary's Hospital; Pusan National University Hospital; Chonnam National University... 그리고 다른 협력자들알려지지 않은
-
Asan Medical Center완전한
-
Seoul National University Hospital완전한
-
Seoul National University Hospital완전한
-
Asan Medical Center모병
-
Kosin University Gospel HospitalInje University알려지지 않은
-
The Catholic University of KoreaKyunghee University; Chonnam National University마케팅 승인
-
Korea University Anam HospitalSeoul National University Hospital; Seoul National University Bundang Hospital; Korea University... 그리고 다른 협력자들완전한
-
Samsung Medical Center모집하지 않고 적극적으로
-
Samsung Medical Center완전한
-
Samsung Medical Center모집하지 않고 적극적으로
-
Seoul National University Hospital완전한유방의 호르몬 수용체 양성 악성 신생물대한민국
-
Samsung Medical Center완전한